Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Gross

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Biomed Research International|July 19, 2019
Multimodality Treatment Options and Outcomes of Laryngeal Carcinosarcoma: A Clinical Analysis of a Rare Tumor from a Single HospitalYang Zhang, Zhigang Huang, Neil Gross, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 26, 2018
Combined Effect of IL-12Rβ2 and IL-23R Expression on Prognosis of Patients with Laryngeal CancerYe Tao, Tianchang Tao, Neil Gross, et al.
Oral Oncology|November 23, 2019
Homologous recombination enhances radioresistance in hypopharyngeal cancer cell line by targeting DNA damage responseChuan Liu, Kui Liao, Neil Gross, et al.
Oral Oncology|June 27, 2012
Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: a pilot randomized trial in head and neck cancerHoward S Moskowitz, William E Gooding, Sufi M Thomas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 24, 2019
High Notch1 expression affects chemosensitivity of head and neck squamous cell carcinoma to paclitaxel and cisplatin treatmentZuping Zhang, Zhongxin Zhou, Mingde Zhang, et al.
Investigative Ophthalmology & Visual Science|May 30, 2019
PD-L1/PD1 Expression, Composition of Tumor-Associated Immune Infiltrate, and HPV Status in Conjunctival Squamous Cell CarcinomaPriyadharsini Nagarajan, Christian El-Hadad, Stephen K Gruschkus, et al.
Head & Neck|April 4, 2017
Improving outcomes in veterans with oropharyngeal squamous cell carcinoma through implementation of a multidisciplinary clinicTyler Light, Edward El Rassi, Ronald J Maggiore, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 28, 2017
Long-term Functional and Quality-of-Life Outcomes After Transoral Robotic Surgery in Patients With Oropharyngeal CancerVirginie Achim, Rachel K Bolognone, Andrew D Palmer, et al.
Translational Oncology|August 14, 2018
Overexpression of miRNA 4451 is Associated With a Poor Survival of Patients With Hypopharyngeal Cancer After Surgery With Postoperative RadiotherapyXinbo Xu, Heng Liu, Neil Gross, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 1, 2013
Prospective study of venous thromboembolism in patients with head and neck cancer after surgeryDaniel R Clayburgh, Will Stott, Teresa Cordiero, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Biomed Research International|July 19, 2019
Multimodality Treatment Options and Outcomes of Laryngeal Carcinosarcoma: A Clinical Analysis of a Rare Tumor from a Single HospitalYang Zhang, Zhigang Huang, Neil Gross, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 26, 2018
Combined Effect of IL-12Rβ2 and IL-23R Expression on Prognosis of Patients with Laryngeal CancerYe Tao, Tianchang Tao, Neil Gross, et al.
Oral Oncology|November 23, 2019
Homologous recombination enhances radioresistance in hypopharyngeal cancer cell line by targeting DNA damage responseChuan Liu, Kui Liao, Neil Gross, et al.
Oral Oncology|June 27, 2012
Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: a pilot randomized trial in head and neck cancerHoward S Moskowitz, William E Gooding, Sufi M Thomas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 24, 2019
High Notch1 expression affects chemosensitivity of head and neck squamous cell carcinoma to paclitaxel and cisplatin treatmentZuping Zhang, Zhongxin Zhou, Mingde Zhang, et al.
Investigative Ophthalmology & Visual Science|May 30, 2019
PD-L1/PD1 Expression, Composition of Tumor-Associated Immune Infiltrate, and HPV Status in Conjunctival Squamous Cell CarcinomaPriyadharsini Nagarajan, Christian El-Hadad, Stephen K Gruschkus, et al.
Head & Neck|April 4, 2017
Improving outcomes in veterans with oropharyngeal squamous cell carcinoma through implementation of a multidisciplinary clinicTyler Light, Edward El Rassi, Ronald J Maggiore, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 28, 2017
Long-term Functional and Quality-of-Life Outcomes After Transoral Robotic Surgery in Patients With Oropharyngeal CancerVirginie Achim, Rachel K Bolognone, Andrew D Palmer, et al.
Translational Oncology|August 14, 2018
Overexpression of miRNA 4451 is Associated With a Poor Survival of Patients With Hypopharyngeal Cancer After Surgery With Postoperative RadiotherapyXinbo Xu, Heng Liu, Neil Gross, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 1, 2013
Prospective study of venous thromboembolism in patients with head and neck cancer after surgeryDaniel R Clayburgh, Will Stott, Teresa Cordiero, et al.
Pageof 6